| Business Type | Exporter, Supplier, Retailer |
| Size | 200 mg |
| Type | Prescription oncology medicine,Prescription anticancer drug |
| Material | Alpelisib |
| Click to view more | |
Product Details
PPiqray (alpelisib) 200 mg tablets are a targeted oral oncology therapy for adults with advanced HR-positive, HER2-negative, PIK3CA-mutated breast cancer, given in combination with fulvestrant. They are taken once daily with food and designed to inhibit tumor growth by targeting a specific genetic driver of cancer cell survival.
Hi! Simply click below and type your query.
Our experts will reply you very soon.